ROSEN, A LEADING NATIONAL FIRM, Encourages NovoCure Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action

NEW YORK, July 03, 2023 (GLOBE NEWSWIRE) —

WHY:

Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of NovoCure Limited (NASDAQ: NVCR) between January 5, 2023 and June 5, 2023, both dates inclusive (the “Class Period”), of the important August 18, 2023 lead plaintiff deadline.

SO WHAT:

If you purchased securities of NovoCure Limited during the Class Period, you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

The lawsuit alleges NovoCure Limited made materially false and/or misleading statements and/or failed to disclose that: (1) the Company’s existing sales force was deteriorating; (2) the Company’s internal marketing collaterals lacked compliance with federal regulations; and (3) as a result, Defendants’ public